Literature DB >> 6586474

The fate of inhaled terbutaline.

D S Davies.   

Abstract

Studies of the metabolic fate of bronchodilator drugs such as terbutaline and isoprenaline lead to the conclusion that less than 10% of an inhaled dose is absorbed from the airways. The remaining 90% is swallowed but is largely prevented from reaching the systemic circulation because of metabolism in the gut wall and liver. However, it is the minor fraction reaching the airways which produces the therapeutic effect. Activated charcoal has been used to prevent absorption of terbutaline from the Gl tract thereby allowing more accurate estimates to be made of pulmonary absorption. The results confirm previous estimates but, in addition, indicate considerable inter-subject variation in pulmonary absorption.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6586474

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN: 0106-4347


  8 in total

1.  Determination of the relative bioavailability of salbutamol to the lung following inhalation.

Authors:  M Hindle; H Chrystyn
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Beta-adrenoceptor responses to inhaled salbutamol in normal subjects.

Authors:  B J Lipworth; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  The biochemical effects of high-dose inhaled salbutamol in patients with asthma.

Authors:  B J Lipworth; R A Clark; C G Fraser; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  A population analysis of nebulized (R)-albuterol in dogs using a novel mixed gut-lung absorption PK-PD model.

Authors:  B Auclair; I W Wainer; K Fried; P Koch; T P Jerussi; M P Ducharme
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

Review 5.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  Investigations of an optimal inhaler technique with the use of urinary salbutamol excretion as a measure of relative bioavailability to the lung.

Authors:  M Hindle; D A Newton; H Chrystyn
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

7.  Hypokalaemia in healthy volunteers after single and multiple doses of formoterol or salbutamol.

Authors:  B T van den Berg; R T Louwerse; G J Luiken; R E Jonkers; C J van Boxtel
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 8.  Clinical pharmacokinetics of beta-agonists.

Authors:  D J Morgan
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.